Literature DB >> 19246698

Additional stroke-related and non-stroke-related cardiovascular costs and hospitalizations in managed-care patients after ischemic stroke.

Craig S Roberts1, Philip B Gorelick, Xin Ye, Carolyn Harley, George A Goldberg.   

Abstract

BACKGROUND AND
PURPOSE: Prior stroke confers an increased risk of future cardiovascular events. Because the incremental economic impact of this added risk is unknown, we assessed the additional cardiovascular costs and hospitalizations associated with ischemic stroke.
METHODS: Patients hospitalized for ischemic stroke during 2002 to 2005 were identified from a large US managed-care plan and matched to control patients hospitalized for a noncardiovascular acute event. Cumulative stroke-related and non-stroke-related cardiovascular medical costs were determined for each group. Stroke and nonstroke cardiovascular hospitalization rates were calculated with the Kaplan-Meier method; risk of hospitalization was estimated with a Cox regression model.
RESULTS: Stroke patients and matched controls (N=11 883) were identified (mean age approximately 58 years; 47.8% female). Compared with controls, patients hospitalized for ischemic stroke had higher stroke and nonstroke cardiovascular medical costs at 6 months (stroke: $1756 vs $50, P<0.01; nonstroke cardiovascular: $1437 vs $658, P<0.01) and 12 months (stroke: $2109 vs $68, P<0.01; nonstroke cardiovascular: $2203 vs $1167, P<0.01) of follow-up. Among stroke patients, cumulative stroke and nonstroke cardiovascular hospitalization rates were 9.06% and 5.63% at 6 months, respectively, and 21.09% and 22.05% at 36 months, respectively. Stroke patients were at significantly increased risk of repeat stroke hospitalization (hazard ratio=12.55; 95% CI, 10.50 to 15.01) and nonstroke cardiovascular hospitalization (hazard ratio=1.95; 95% CI, 1.77 to 2.14).
CONCLUSIONS: After ischemic stroke, patients have significantly greater stroke and nonstroke cardiovascular costs and hospitalizations than do matched controls. Attention to total cardiovascular risk reduction in this population could potentially reduce downstream costs.

Entities:  

Mesh:

Year:  2009        PMID: 19246698     DOI: 10.1161/STROKEAHA.108.534354

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Initial blood pressure is associated with stroke severity and is predictive of admission cost and one-year outcome in different stroke subtypes: a SRICHS registry study.

Authors:  Chi-Hung Liu; Yi-Chia Wei; Jr-Rung Lin; Chien-Hung Chang; Ting-Yu Chang; Kuo-Lun Huang; Yeu-Jhy Chang; Shan-Jin Ryu; Leng-Chieh Lin; Tsong-Hai Lee
Journal:  BMC Neurol       Date:  2016-02-29       Impact factor: 2.474

Review 2.  Patient-level costs of major cardiovascular conditions: a review of the international literature.

Authors:  Gina Nicholson; Shravanthi R Gandra; Ronald J Halbert; Akshara Richhariya; Robert J Nordyke
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-21

3.  Impact of atrial fibrillation on stroke-related healthcare costs.

Authors:  Matthew Sussman; Joseph Menzin; Iris Lin; Winghan J Kwong; Michael Munsell; Mark Friedman; Magdy Selim
Journal:  J Am Heart Assoc       Date:  2013-11-25       Impact factor: 5.501

4.  A Retrospective Study to Examine Healthcare Costs Related to Cardiovascular Events in Individuals with Hyperlipidemia.

Authors:  Henry J Henk; Carly J Paoli; Shravanthi R Gandra
Journal:  Adv Ther       Date:  2015-11-19       Impact factor: 3.845

5.  Prognostic Value of Coronary CT Angiography for Predicting Poor Cardiac Outcome in Stroke Patients without Known Cardiac Disease or Chest Pain: The Assessment of Coronary Artery Disease in Stroke Patients Study.

Authors:  Sung Hyun Yoon; Eunhee Kim; Yongho Jeon; Sang Yoon Yi; Hee Joon Bae; Ik Kyung Jang; Joo Myung Lee; Seung Min Yoo; Charles S White; Eun Ju Chun
Journal:  Korean J Radiol       Date:  2020-09       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.